发明名称 THE USE OF NAPHTOQUINONES IN THE TREATMENT AND CONTROL OF DIABETES, INSULIN RESISTANCE AND HYPERGLYCEMIA
摘要 <p>The present invention relates to naphthoquinon derivit ives and closely related compounds or tautomers or stereoiso meric forms thereof for the prophylaxis or treatment of metabolic disorders mediated by insulin resistance or hyperglycaemia, comprising diabetes type 2, inadequate glucose tolerance, insulin resistance, obesity, polycyst ic ovary syndro me (PCOS), hypertensio n and the metabolic syndrome. The invention also relates to compositions comprising a naphthoquinone derivative, a flavone derivative, warfarin or dicumarol, as an anti-diabetic agent, and to methods for prophylaxis or treatment of the above-mentioned medical conditions.</p>
申请公布号 EP2046313(A1) 申请公布日期 2009.04.15
申请号 EP20070769053 申请日期 2007.07.06
申请人 GLUCOX BIOTECH AB 发明人 WILCKE, MONA;SVENSSON, BO;WALSE, BJOERN;BENGTSSON, TORE
分类号 A61K31/122;A61K31/37;A61P3/04;A61P3/06;A61P3/08;A61P3/10 主分类号 A61K31/122
代理机构 代理人
主权项
地址